IVC Industries sales rise 28.9% to $31.6 mil. in first quarter, paced by Fields of Nature.
This article was originally published in The Tan Sheet
IVC INDUSTRIES SALES RISE 28.9% TO $31.6 MIL. IN FIRST QUARTER ended Oct. 31, paced by IVC's best-selling vitamins and supplements line, the Fields of Nature brand, the company reported Dec. 11. Fields of Nature posted revenues of "over 15%" of total sales or approximately $4.7 mil., up from about $2.9 mil. -- 12% of sales -- in the prior-year quarter. IVC is planning to extend the brand with more than a dozen new products early in 1997
You may also be interested in...
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Coherus BioSciences is aiming to translate the success of its comprehensive biosimilar pegfilgrastim strategy to adalimumab, with plans to capture at least 10% of the US market upon formation in 2023. Management summarized the firm’s expectations during the company’s fourth-quarter earnings call, which revealed a downturn in pegfilgrastim sales and profitability.